Active, not recruitingPhase 2NCT01841736

Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors

Studying Germ cell tumor

Last synced from ClinicalTrials.gov May 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: National Cancer Institute (NCI)
Principal Investigator: Emily K Bergsland
Alliance for Clinical Trials in Oncology
Intervention: Biospecimen Collection(procedure)
Enrollment: 171 target
Eligibility: 18 years · All sexes
Timeline: 2013 – 2026

Study locations (30)

Alaska Breast Care and Surgery LLC, Anchorage, Alaska, United States
Alaska Women's Cancer Care, Anchorage, Alaska, United States
Anchorage Oncology Centre, Anchorage, Alaska, United States
Katmai Oncology Group, Anchorage, Alaska, United States
Providence Alaska Medical Center, Anchorage, Alaska, United States
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
Kaiser Permanente-Anaheim, Anaheim, California, United States
Kaiser Permanente-Baldwin Park, Baldwin Park, California, United States
Kaiser Permanente-Fontana, Fontana, California, United States
Kaiser Permanente South Bay, Harbor City, California, United States
Kaiser Permanente-Irvine, Irvine, California, United States
Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, United States
Los Angeles General Medical Center, Los Angeles, California, United States
USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States
Kaiser Permanente West Los Angeles, Los Angeles, California, United States
+15 more locations on ClinicalTrials.gov

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01841736 on ClinicalTrials.gov

Other trials for Germ cell tumor

Additional recruiting or active studies for the same condition.

See all trials for Germ cell tumor →

← Back to all trials